NEWS

Media

06

May | 2020

Cannabics Pharmaceuticals Files Provisional Patent on Composition and Method for Treating Colon Cancer With Cannabinoids

TEL AVIV, Israel and BETHESDA, Maryland, May 6, 2020 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focu

27

April | 2020

Cannabics Pharmaceuticals Appoints Prof. Zamir Halpern to Its Scientific Board of Advisors

TEL AVIV, Israel and BETHESDA, Maryland, April 27, 2020 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine foc

13

April | 2020

Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon Cancer

TEL AVIV, Israel and BETHESDA, Maryland, April 13, 2020 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine foc

25

March | 2020

Cannabics Pharmaceuticals Study Shows Complex Combinatorial Anti-tumor Activity of Cannabinoids

TEL AVIV, Israel and BETHESDA, Maryland, March 25, 2020 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine foc

18

March | 2020

Cannabics Pharmaceuticals Offers Its High Throughput Screening (HTS) Platform to the Israeli Health Authorities for SARS-CoV-2 Research

TEL AVIV, Israel and BETHESDA, Maryland, March 18, 2020 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine foc

11

March | 2020

Cannabics Pharmaceuticals Shows Specific Cultivars Identified to Have Positive Anti-Tumor Effects on Gastric Adenocarcinoma

TEL AVIV, Israel and BETHESDA, Maryland, March 11, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabino

02

March | 2020

Cannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells

TEL AVIV, Israel and BETHESDA, Maryland, March 2, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

25

February | 2020

Cannabics Pharmaceuticals Partners With NewCanna to Commence Research Based on Colombian Indigenous Cannabis Landraces

TEL AVIV, Israel and BETHESDA, Maryland, Feb. 25, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

18

February | 2020

Cannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non-acidic Form

TEL AVIV, Israel and BETHESDA, Maryland, Feb. 18, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

11

February | 2020

Cannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting Gastrointestinal Cancers

TEL AVIV, Israel and BETHESDA, Maryland, Feb. 11, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

27

January | 2020

Cannabics Pharmaceuticals Study Shows Cannabinoids CBC and CBG Exhibit

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 27, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

09

January | 2020

Cannabics Pharmaceuticals Announces Cannabigerol (CBG) Shown to Have Anti-tumor Properties

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 9, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid

31

December | 2019

Cannabics Pharmaceuticals to be present during the J.P. Morgan Healthcare Conference In San Francisco

TEL AVIV, Israel and BETHESDA, Md., Dec. 31, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid med

05

December | 2019

Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research

TEL AVIV, Israel and BETHESDA, Maryland, Dec. 5, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid

16

October | 2019

Cannabics Pharmaceuticals Announces Publication of Clinical Data From Its Sponsored Pilot Study on Controlled Release Capsules, on the Journal of Integrative Cancer Therapies

TEL AVIV, Israel and BETHESDA, Maryland, Oct. 16, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

07

October | 2019

Cannabics Pharmaceuticals Appoints Company’s Founder to Its Board of Directors

TEL AVIV, Israel and BETHESDA, Maryland, Oct. 7, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid

12

September | 2019

Cannabics Pharmaceuticals to Present Research Data at the 2nd International Cannabinoid Derived Pharmaceuticals Summit in Boston, MA

TEL AVIV, Israel and BETHESDA, Maryland, Sept. 12, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC-QB: CNBX), a leader in personalized cannabis

28

June | 2019

Wize Pharma Completes Milestone for Joint Venture With Cannabics Pharmaceuticals; Companies to Develop Cannabinoid Ophthalmic Treatments

HOD HASHARON, Israel, June 28, 2019 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment

25

June | 2019

Cannabics Pharmaceuticals Appoints Two Independent Directors

TEL AVIV, Israel and BETHESDA, Maryland, June 25, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

04

June | 2019

Cannabics Pharmaceuticals to Participate at the LIFT & Co. Conference in Toronto, Canada

TEL AVIV, Israel and BETHESDA, Maryland, June 4, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid

30

May | 2019

Cannabics Pharmaceuticals to Participate at the 9th Annual LD Micro Invitational in Bel Air, California Press Release |

TEL AVIV, ISRAEL and BETHESDA, MD / ACCESSWIRE / May 30, 2019 / Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medic

17

April | 2019

Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies

TEL AVIV, Israel and BETHESDA, Maryland, April 17, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabi

13

March | 2019

OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

NEW YORK, March 13, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, to

12

March | 2019

SodaStream CEO Daniel Birnbaum to Join Seedo Board

TEL AVIV, Israel and BETHESDA, Maryland, March 12, 2019 Cannabics Pharmaceuticals Inc. (OTCQB:CNBX), a leader in personalized cannabinoid medicine foc

06

March | 2019

Wize Pharma, Inc. Closes Deal to Launch Joint Venture With Cannabics

HOD HASHARON, Israel, March 6, 2019 /PRNewswire/ -- Wize Pharma, Inc. ("Wize Pharma" or the "Company") (OTCQB: WIZP) a clinical-stage biopharmaceutical

06

March | 2019

Cannabics Pharmaceuticals Closes Agreement With Wize Pharma

BETHESDA, Maryland and TEL AVIV, Israel, March 6, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) a world leader in personalized canna

19

February | 2019

Cannabics Pharmaceuticals Submits Protocol for an Ex-Vivo Clinical Study on Biopsies and Cannabinoids

TEL AVIV, Israel and BETHESDA, Maryland, Feb. 19, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB:CNBX), a leader in personalized cannabinoid

07

February | 2019

Cannabics Pharmaceuticals and Wize Pharma to Form Joint Venture to Develop Cannabinoid Based Ophthalmic Therapeutics

BETHESDA, Maryland and TEL AVIV, Israel, Feb. 7, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) a world leader in personalized cannab

07

February | 2019

Wize Pharma, Inc. Signs Joint Venture With Cannabics, to Research and Develop Cannabinoid Formulations to Treat Ophthalmic Conditions

HOD HASHARON, Israel, Feb. 7, 2019 /PRNewswire/ -- Wize Pharma, Inc. ("Wize Pharma" or the "Company") (OTCQB: WIZP) a clinical-stage biopharmaceutical c

31

January | 2019

Cannabics Pharmaceuticals Files Four New Provisional Patent Applications for Cannabinoid-Based Drugs and Treatments for Non-Epileptic Seizures and Tremors

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 31, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

24

January | 2019

Cannabics Pharmaceuticals and NewCanna Hub Intend to Collaborate to Manufacture and Market Cannabics’ SR Capsules in Colombia

PR Newswire TEL AVIV, Israel and BETHESDA, Maryland, Jan. 24, 2019 TEL AVIV, Israel and BETHESDA, Maryland, Jan. 24, 2019 /PRNewswire/ -- Cannabic

22

January | 2019

Cannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 22, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

08

January | 2019

Cannabics Pharmaceuticals Converts $1 Million Loan Into Common Shares of Seedo

TEL AVIV, Israel, Jan. 8, 2019 /PRNewswire/ -- Seedo Corp. (OTC: SEDO), a high-tech company providing the world's first fully automated and controlled i

26

December | 2018

Cannabics Pharmaceuticals Announces New Provisional Patent Application for Personalized Cannabimetic Compositions Modeling and Production

TEL AVIV, Israel and BETHESDA, Maryland, Dec. 26, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (NASDAQ: CNBX), a world leader in personalized can

11

December | 2018

Cannabics Pharmaceuticals Prepares ISO Application for Its Diagnostics Platform Towards Commercialization

TEL AVIV, Israel and BETHESDA, Maryland, Dec. 11, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a world leader in personalized cann

28

November | 2018

Cannabics Pharmaceuticals Received a New Research License for Characterization of Anti-Tumor Activity of Cannabinoids

TEL-AVIV, Israel, Nov. 28, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) announced today that it has received a new research license from

28

November | 2018

Cannabics Pharmaceuticals Announces New Provisional Patent Application for Magnetic Targeting of Cannabinoids

TEL AVIV, Israel and BETHESDA, Maryland, Nov. 28, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a world leader in personalized cann

27

November | 2018

CEO of Cannabics Pharmaceuticals Presenting at 11th Annual LD Micro Conference, on December 5th, 2018 in LA, California

TEL AVIV, Israel and BETHESDA, Maryland, Nov. 27, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin

06

November | 2018

Cannabics Pharmaceuticals Inc. CEO talks with Uptick Newswire’s Stock Day Podcast About Cancer Research in the Cannabinoid Sector Press Release |

PHOENIX, Ariz., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) (the “Company”) is a U.S public company that is developin

01

November | 2018

CEO of Cannabics Pharmaceutical Speaking at MJBizCon 2018 in Las Vegas

TEL AVIV, Israel and BETHESDA, Maryland, Nov. 1, 2018 /PRNewswire/ --  Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin